143 related articles for article (PubMed ID: 30829551)
21. Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy.
Kim KW; Chow O; Parikh K; Blank S; Jibara G; Kadri H; Labow DM; Hiotis SP
Am J Surg; 2014 Jan; 207(1):78-83. PubMed ID: 24157224
[TBL] [Abstract][Full Text] [Related]
22. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
[TBL] [Abstract][Full Text] [Related]
23. [A case of gastric cancer with peritoneal dissemination which has been alive more than three years responding to intraperitoneal chemotherapy].
Asami S; Idani H; Kubo S; Sasaki H; Kurose Y; Nojima H; Yoshioka T; Muro M; Kumano K; Hirata M; Yamashita T; Kin H; Takakura N
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2287-9. PubMed ID: 20037398
[TBL] [Abstract][Full Text] [Related]
24. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.
Shim HJ; Kim KR; Hwang JE; Bae WK; Ryu SY; Park YK; Nam TK; Chung IJ; Cho SH
Cancer Chemother Pharmacol; 2016 Mar; 77(3):605-12. PubMed ID: 26846507
[TBL] [Abstract][Full Text] [Related]
25. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center.
Wu HT; Peng KW; Ji ZH; Sun JH; Zhang Q; Yang XJ; Huang CQ; Li Y
Eur J Surg Oncol; 2016 Jul; 42(7):1024-34. PubMed ID: 27179924
[TBL] [Abstract][Full Text] [Related]
26. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer.
Yan TD; Black D; Sugarbaker PH; Zhu J; Yonemura Y; Petrou G; Morris DL
Ann Surg Oncol; 2007 Oct; 14(10):2702-13. PubMed ID: 17653801
[TBL] [Abstract][Full Text] [Related]
27. Fibrin-sealant-delivered cisplatin chemotherapy versus cisplatin hyperthermic intraperitoneal perfusion chemotherapy for locally advanced gastric cancer without peritoneal metastases: a randomized phase-II clinical trial with a 40-month follow-up.
Huang O; Lu X; Xu X; Shi Y
Cell Biochem Biophys; 2015 Mar; 71(2):1171-80. PubMed ID: 25398590
[TBL] [Abstract][Full Text] [Related]
28. Long-term survival of 5 years following initial surgery for gastric cancer and simultaneous disseminated peritoneal metastasis: report of a case.
Otani S; Maeta M; Oka A; Hirooka Y; Tsujitani S; Ikeguchi M; Hamazoe R; Kaibara N
Surg Today; 1995; 25(11):959-61. PubMed ID: 8640021
[TBL] [Abstract][Full Text] [Related]
29. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract][Full Text] [Related]
30. Phase II trial of neoadjuvant chemotherapy with intraperitoneal paclitaxel, S-1, and intravenous cisplatin and paclitaxel for stage IIIA or IIIB gastric cancer.
Shinkai M; Imano M; Chiba Y; Iwama M; Shiraisi O; Yasuda A; Tsubaki M; Nishida S; Kimura Y; Yasuda T
J Surg Oncol; 2019 Jan; 119(1):56-63. PubMed ID: 30444009
[TBL] [Abstract][Full Text] [Related]
31. A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP).
Kim JY; Bae HS
Gastric Cancer; 2001; 4(1):27-33. PubMed ID: 11706624
[TBL] [Abstract][Full Text] [Related]
32. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination.
Yonemura Y; Fujimura T; Fushida S; Takegawa S; Kamata T; Katayama K; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
World J Surg; 1991; 15(4):530-5; discussion 535-6. PubMed ID: 1891941
[TBL] [Abstract][Full Text] [Related]
33. Gene expression changes induced by HIPEC in a murine model of gastric cancer.
Graziosi L; Mencarelli A; Renga B; Santorelli C; Cantarella F; Bugiantella W; Cavazzoni E; Donini A; Fiorucci S
In Vivo; 2012; 26(1):39-45. PubMed ID: 22210714
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in patients with advanced gastric cancer treated by noncurative resection: a multivariate analysis.
Tsujitani S; Oka S; Suzuki K; Saito H; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Hepatogastroenterology; 2001; 48(41):1504-8. PubMed ID: 11677996
[TBL] [Abstract][Full Text] [Related]
35. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y
Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799
[TBL] [Abstract][Full Text] [Related]
36. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
[TBL] [Abstract][Full Text] [Related]
37. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
Fu S; Lu JJ; Zhang Q; Yang Z; Peng L; Xiong F
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1488-94. PubMed ID: 18538489
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II study.
Newman E; Potmesil M; Ryan T; Marcus S; Hiotis S; Yee H; Norwood B; Wendell M; Muggia F; Hochster H
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S97-100. PubMed ID: 16399443
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
[TBL] [Abstract][Full Text] [Related]
40. Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer.
Noh SH; Yoo CH; Chung HC; Roh JK; Shin DW; Min JS
Oncology; 2001; 60(1):24-30. PubMed ID: 11150904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]